Moving the Needle for Oncology Dose Optimization: A Call for Action.

Venkatakrishnan, Karthik; Jayachandran, Priya; Seo, Shirley K; van der Graaf, Piet H; Wagner, John A; Gupta, Neeraj

Venkatakrishnan, Karthik; Jayachandran, Priya; Seo, Shirley K; van der Graaf, Piet H; Wagner, John A; Gupta, Neeraj.

Afiliação

Venkatakrishnan K; EMD Serono Research and Development Institute, Inc., Billerica, Massachusetts, USA.
Jayachandran P; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
Seo SK; Division of Cardiometabolic and Endocrine Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
van der Graaf PH; Certara, Canterbury, UK.
Wagner JA; Leiden University, Leiden, The Netherlands.
Gupta N; Koneksa Health, New York, New York, USA.

Clin Pharmacol Ther ; 115(6): 1187-1197, 2024 Jun.

Article em En | MEDLINE | ID: mdl-38736240

Assuntos

Antineoplásicos; Neoplasias; Humanos; Neoplasias/tratamento farmacológico; Antineoplásicos/administração & dosagem; Relação Dose-Resposta a Droga; Oncologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google